Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US7541357B2 · kind B2 · utility
15Cited by
18References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2005 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Nov 7, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of the present invention are represented by the chemical structure found in Formula (I):wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.